Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
575
-
Total 13F shares, excl. options
-
181M
-
Shares change
-
-1.59M
-
Total reported value, excl. options
-
$12.8B
-
Value change
-
-$83.7M
-
Put/Call ratio
-
0.74
-
Number of buys
-
334
-
Number of sells
-
-221
-
Price
-
$70.69
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q1 2025
673 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q1 2025.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 575 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 181M shares
of 194M outstanding shares and own 93.53% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (23.8M shares), VANGUARD GROUP INC (19M shares), PRIMECAP MANAGEMENT CO/CA/ (17.8M shares), Dodge & Cox (15M shares), VIKING GLOBAL INVESTORS LP (10.8M shares), Capital Research Global Investors (9.15M shares), STATE STREET CORP (8.46M shares), AMERIPRISE FINANCIAL INC (4.21M shares), Elliott Investment Management L.P. (3.5M shares), and GEODE CAPITAL MANAGEMENT, LLC (3.43M shares).
This table shows the top 575 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.